BRPI0507848A - composição farmacêutica para aplicação oral e método para prepará-la - Google Patents

composição farmacêutica para aplicação oral e método para prepará-la

Info

Publication number
BRPI0507848A
BRPI0507848A BRPI0507848-2A BRPI0507848A BRPI0507848A BR PI0507848 A BRPI0507848 A BR PI0507848A BR PI0507848 A BRPI0507848 A BR PI0507848A BR PI0507848 A BRPI0507848 A BR PI0507848A
Authority
BR
Brazil
Prior art keywords
preparing
pharmaceutical composition
oral application
composition
oral
Prior art date
Application number
BRPI0507848-2A
Other languages
English (en)
Inventor
Claudia Mattern
Wilfried Pieper
Original Assignee
Udo Mattern
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Udo Mattern filed Critical Udo Mattern
Publication of BRPI0507848A publication Critical patent/BRPI0507848A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

COMPOSIçãO FARMACêUTICA PARA APLICAçãO ORAL E MéTODO PARA PREPARá-LA. A presente invenção refere-se a uma composição farmacêutica para aplicação oral contendo: i) um agente anti-helmíntico; ii) um primeiro excipiente tendo uma estrutura porosa com uma superfície interna de cerca de 500 a cerca de 1500 m¬ 2¬/g e uma área superficial de acordo com BET de até cerca de 5000 m¬ 2¬g; bem como a um método de preparação de tal composição.
BRPI0507848-2A 2004-02-20 2005-02-09 composição farmacêutica para aplicação oral e método para prepará-la BRPI0507848A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04003906A EP1566173B1 (en) 2004-02-20 2004-02-20 Pharmaceutical composition for oral application and method for preparing thereof
PCT/EP2005/001297 WO2005079759A2 (en) 2004-02-20 2005-02-09 Pharmaceutical composition for oral application and method for preparing thereof

Publications (1)

Publication Number Publication Date
BRPI0507848A true BRPI0507848A (pt) 2007-07-10

Family

ID=34707350

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507848-2A BRPI0507848A (pt) 2004-02-20 2005-02-09 composição farmacêutica para aplicação oral e método para prepará-la

Country Status (16)

Country Link
US (1) US7767228B2 (pt)
EP (2) EP1566173B1 (pt)
JP (1) JP4800225B2 (pt)
AT (1) ATE336230T1 (pt)
AU (1) AU2005215108B2 (pt)
BR (1) BRPI0507848A (pt)
CA (1) CA2554640C (pt)
DE (1) DE602004001969T2 (pt)
DK (1) DK1566173T3 (pt)
ES (1) ES2271714T3 (pt)
NO (1) NO20064240L (pt)
PT (1) PT1566173E (pt)
RU (1) RU2342936C2 (pt)
SI (1) SI1566173T1 (pt)
WO (1) WO2005079759A2 (pt)
ZA (1) ZA200606554B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2429095T3 (es) * 2005-05-18 2013-11-13 Da Volterra Aporte colónico de adsorbentes
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
UY31410A1 (es) * 2007-10-30 2009-05-29 Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado
JP2010106007A (ja) * 2008-08-14 2010-05-13 Sony Corp 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート
NZ593217A (en) * 2008-12-05 2013-05-31 Bayer Ip Gmbh Extrudate having spicular active substances
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
RU2514056C2 (ru) * 2012-08-21 2014-04-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ инкапсуляции фенбендазола
JP6472341B2 (ja) * 2015-06-26 2019-02-20 株式会社トーヨー技術研究所 固形状の魚類用経口投与薬剤、当該薬剤を含む養魚用飼料、および当該薬剤を魚に投与する方法
EP4208157A1 (en) 2020-09-04 2023-07-12 Elanco Us Inc. Palatable formulations
CN117915955A (zh) 2021-08-31 2024-04-19 株式会社东洋技术研究所 水栖动物用经口给药药剂
CN117881425A (zh) * 2021-08-31 2024-04-12 株式会社东洋技术研究所 水栖动物用经口给药药剂

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1879601A (en) * 1926-03-13 1932-09-27 Merck & Co Inc Iodine composition
BE634024A (pt) * 1962-06-25
US3709833A (en) * 1970-08-21 1973-01-09 Owens Illinois Inc Process for preparing high purity silicon oxide porous beads doped with small quantities of other oxides
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
SU1465052A1 (ru) * 1985-06-10 1989-03-15 Институт Зоологии Ан Казсср Способ профилактики и лечени гельминтозов животных
US5013716A (en) * 1988-10-28 1991-05-07 Warner-Lambert Company Unpleasant taste masking compositions and methods for preparing same
JPH05238930A (ja) * 1992-02-28 1993-09-17 Eisai Co Ltd 持続性薬剤
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5827497A (en) * 1996-08-14 1998-10-27 Mayo Foundation For Medical Education And Research Charcoal-radionuclide agents for measurement of gastrointestinal transit
WO1998053802A1 (en) * 1997-05-30 1998-12-03 Laboratorios Phoenix U.S.A., Inc. Multi-layered osmotic device
DE19726412A1 (de) * 1997-06-21 1998-12-24 Merck Patent Gmbh Implantatmaterial mit einer Träger-Wirkstoff-Kombination
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JP3834732B2 (ja) * 1998-08-05 2006-10-18 株式会社ロッテ チューインガム
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6491949B2 (en) * 2000-01-14 2002-12-10 Osmotica Corp. Osmotic device within an osmotic device
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
EP1362583A1 (de) * 2002-05-15 2003-11-19 CUM Taste Masking AG Verfahren zur Geschmacksmaskierung von Substanzen durch Mikroverkapselung
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
JP4603357B2 (ja) * 2002-08-13 2010-12-22 インターベツト・インターナシヨナル・ベー・ベー 添加剤をデリバリーするための組成物及び方法
CN100347889C (zh) * 2002-10-31 2007-11-07 松下电器产业株式会社 多孔电极及使用该电极的电化学元件

Also Published As

Publication number Publication date
ATE336230T1 (de) 2006-09-15
SI1566173T1 (sl) 2006-12-31
AU2005215108A1 (en) 2005-09-01
DK1566173T3 (da) 2006-12-27
EP1566173B1 (en) 2006-08-16
NO20064240L (no) 2006-11-20
PT1566173E (pt) 2006-12-29
JP2007523108A (ja) 2007-08-16
WO2005079759A3 (en) 2006-06-15
CA2554640C (en) 2011-04-12
ZA200606554B (en) 2008-05-28
DE602004001969T2 (de) 2007-03-15
WO2005079759A2 (en) 2005-09-01
EP1715850A2 (en) 2006-11-02
US20050186272A1 (en) 2005-08-25
RU2006133543A (ru) 2008-04-10
AU2005215108B2 (en) 2010-10-07
US7767228B2 (en) 2010-08-03
DE602004001969D1 (de) 2006-09-28
RU2342936C2 (ru) 2009-01-10
CA2554640A1 (en) 2005-09-01
JP4800225B2 (ja) 2011-10-26
ES2271714T3 (es) 2007-04-16
EP1566173A1 (en) 2005-08-24

Similar Documents

Publication Publication Date Title
BRPI0507848A (pt) composição farmacêutica para aplicação oral e método para prepará-la
NO2020010I1 (no) fostamatinib eller et farmasøytisk akseptabelt salt av fostamatinib, eller et hydrat, solvat eller N-oksid av fostamatinib eller det farmasøytisk akseptable saltet av fostamatinib, spesielt fostamatinib dinatrium, eventuelt på form av et hydrat
DK1959992T3 (da) Immunogen sammensætning indeholdende en adjuvans.
CL2007001918A1 (es) Compuestos derivados heteroarilos sustituidos; metodo para la preparacion de los compuestos; composicion farmaceutica; y uso para el tratamiento del dolor, depresion, enfermedad de alzheimer e hipertension entre otras.
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
BRPI0816553A2 (pt) "composto, composição farmcêutica, uso de uma composição, uso de um composto, e, processo para a preparação de um composto"
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
DK1896063T3 (da) Immunogen sammensætning
EA200701461A1 (ru) Способ получения лансопразола
FR2898498B1 (fr) Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
FR2881652B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesuage
FR2892937B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesusage
EE200300329A (et) Meetod peroraalselt manustatavate epotiloonide biosaadavuse suurendamiseks ning selles kasutatav komplekt, ravimkoostis ja farmatseutiline ravimvorm
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
AR054129A1 (es) Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7
GT200400146A (es) Derivados sustituidos del dioxido de tiazol-benzoisotiazol, procedimiento para su preparacion y su uso
FR2898499B1 (fr) Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
GT200600161A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
CY1110034T1 (el) Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν
CY1112960T1 (el) Παραγωγα ουριας, μεθοδοι για την παρασκευη τους και χρησεις αυτων
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
CL2007003189A1 (es) Compuestos derivados de indol y benzofurano; composicion farmaceutica; y uso para el tratamiento o la prevencion de la enfermedad de alzheimer.
ECSP066564A (es) Formulaciones de tableta de liberación extendida de venlafaxina
NI200700175A (es) Procesos para la preparación de alcoholes de aminoetoxibencilo

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2364 DE 26-04-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.